BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17850748)

  • 1. Fragile X mental retardation syndrome: structure of the KH1-KH2 domains of fragile X mental retardation protein.
    Valverde R; Pozdnyakova I; Kajander T; Venkatraman J; Regan L
    Structure; 2007 Sep; 15(9):1090-8. PubMed ID: 17850748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into Fragile X syndrome. Relating genotype to phenotype at the molecular level.
    Pozdnyakova I; Regan L
    FEBS J; 2005 Feb; 272(3):872-8. PubMed ID: 15670167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of KH domains.
    Valverde R; Edwards L; Regan L
    FEBS J; 2008 Jun; 275(11):2712-26. PubMed ID: 18422648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C terminus of fragile X mental retardation protein interacts with the multi-domain Ran-binding protein in the microtubule-organising centre.
    Menon RP; Gibson TJ; Pastore A
    J Mol Biol; 2004 Oct; 343(1):43-53. PubMed ID: 15381419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP.
    Linder B; Plöttner O; Kroiss M; Hartmann E; Laggerbauer B; Meister G; Keidel E; Fischer U
    Hum Mol Genet; 2008 Oct; 17(20):3236-46. PubMed ID: 18664458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding.
    Adinolfi S; Ramos A; Martin SR; Dal Piaz F; Pucci P; Bardoni B; Mandel JL; Pastore A
    Biochemistry; 2003 Sep; 42(35):10437-44. PubMed ID: 12950170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile X syndrome: from molecular genetics to therapy.
    D'Hulst C; Kooy RF
    J Med Genet; 2009 Sep; 46(9):577-84. PubMed ID: 19724010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells.
    Schrier M; Severijnen LA; Reis S; Rife M; van't Padje S; van Cappellen G; Oostra BA; Willemsen R
    Exp Neurol; 2004 Oct; 189(2):343-53. PubMed ID: 15380484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fragile X mental retardation protein has nucleic acid chaperone properties.
    Gabus C; Mazroui R; Tremblay S; Khandjian EW; Darlix JL
    Nucleic Acids Res; 2004; 32(7):2129-37. PubMed ID: 15096575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational and dynamic properties of the KH1 domain of FMRP and its fragile X syndrome linked G266E variant.
    Catalano F; Santorelli D; Astegno A; Favretto F; D'Abramo M; Del Giudice A; De Sciscio ML; Troilo F; Giardina G; Di Matteo A; Travaglini-Allocatelli C
    Biochim Biophys Acta Proteins Proteom; 2024 Jul; 1872(4):141019. PubMed ID: 38641086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X syndrome, the Fragile X related proteins, and animal models.
    Hoogeveen AT; Willemsen R; Oostra BA
    Microsc Res Tech; 2002 May; 57(3):148-55. PubMed ID: 12112450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear microspherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons.
    Davidovic L; Bechara E; Gravel M; Jaglin XH; Tremblay S; Sik A; Bardoni B; Khandjian EW
    Hum Mol Genet; 2006 May; 15(9):1525-38. PubMed ID: 16571602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fragile X mental retardation protein interacts with a distinct mRNA nuclear export factor NXF2.
    Lai D; Sakkas D; Huang Y
    RNA; 2006 Aug; 12(8):1446-9. PubMed ID: 16790844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamics of the fragile X mental retardation protein RGG box interactions with G quartet forming RNA.
    Zanotti KJ; Lackey PE; Evans GL; Mihailescu MR
    Biochemistry; 2006 Jul; 45(27):8319-30. PubMed ID: 16819831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-brain expression analysis of FMRP in adult monkey and its relationship to cognitive deficits in fragile X syndrome.
    Zangenehpour S; Cornish KM; Chaudhuri A
    Brain Res; 2009 Apr; 1264():76-84. PubMed ID: 19368811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of messenger RNAs and microRNAs associated with fragile X mental retardation protein.
    Duan R; Jin P
    Methods Mol Biol; 2006; 342():267-76. PubMed ID: 16957381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fragile X syndrome: exploring its molecular basis and seeking a treatment.
    Bardoni B; Davidovic L; Bensaid M; Khandjian EW
    Expert Rev Mol Med; 2006 Apr; 8(8):1-16. PubMed ID: 16626504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts.
    Castets M; Schaeffer C; Bechara E; Schenck A; Khandjian EW; Luche S; Moine H; Rabilloud T; Mandel JL; Bardoni B
    Hum Mol Genet; 2005 Mar; 14(6):835-44. PubMed ID: 15703194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-Binding Specificity of the Human Fragile X Mental Retardation Protein.
    Athar YM; Joseph S
    J Mol Biol; 2020 Jun; 432(13):3851-3868. PubMed ID: 32343993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs.
    Darnell JC; Fraser CE; Mostovetsky O; Darnell RB
    Hum Mol Genet; 2009 Sep; 18(17):3164-77. PubMed ID: 19487368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.